Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
54
result was found. Results that relate to
Safety
A clinical study of donepezil and buryphthalide in the treatment of Parkinson's syndrome
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1184-1191.
1075 times
221 times
SHE Canfang
ZHOU Meijun
ZHENG Miao
YU Huiyun
Parkinson's syndrome
Butylphthalein sequential therapy
Clinical efficacy
Safety
Details
Data-mining of piperacillin-tazobactam related adverse drug event signals based on FAERS
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1231-1239.
1130 times
265 times
LIU Jinwei
DONG Junli
SHAO Yu
ZHANG Shaohui
Piperacillin tazobactam
Adverse drug event
FAERS database
Signal mining
Diseases of blood and lymphatic system
Medication safety
Details
Antifibrinolytic drugs used in pediatric cardiac surgery: a systematic review and Meta-analysis
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1257-1264.
1141 times
235 times
WANG Qian
LIANG Xingchi
YANG Xinghai
LIU Jun
Cardiac surgery
Extracorporeal circulation
Antifibrinolytic drugs
Peptidase
Tranexamic acid
Aminocaproic acid
Cardiopulmonary
Hemostasis
Safety
Details
Ertugliflozin in the treatment of type 2 diabetes mellitus: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(7):778-789.
1233 times
292 times
QIN Fang
WU Kunrong
LIU Chengyu
LIU Daihua
Ertugliflozin
Type 2 diabetes mellitus
Efficacy
Safety
Cost-effectiveness
Rapid health technology assessment
Details
Romiplostim for the treatment of primary immune thrombocytopenia in adults: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(8):909-918.
992 times
289 times
LI Jie
XIE Jun
HAN Yi
MENG Ying
GAO Liyuan
SHI Xiaohui
JIANG Zhitao
Romiplostim
Primary immune thrombocytopenia
Efficacy
Safety
Economic
Rapid health technology assessment
Details
Bibliometric analysis of active surveillance of post-marketing drug safety
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1054-1063.
1079 times
212 times
WANG Conghui
YANG Ziming
WANG Zhenxing
SHI Wei
ALATENG Hua
XI Chengwei
PI Songning
YUAN Xinmin
ZHAN Siyan
Surveillance of post-marketing safety of drugs
Active surveillance
Pharmacovigilance
Bibliometrics
Visualization analysis
Details
Edaravone in the treatment of acute ischemic stroke: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(10):1147-1155.
350 times
67 times
YU Fang
ZENG Lu
WEI Anhua
GONG Xuepeng
WANG Lu
Edaravone
Acute ischemic stroke
Efficacy
Safety
Economy
Rapid health technology assessment
Details
Efgartigimod alfa in the treatment of generalized myasthenia gravis: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(10):1156-1163.
338 times
68 times
HUANG Gerile
LI Yujie
ZHANG Wenjing
GUO Hao
Efgartigimod alfa
Myasthenia gravis
Rapid health technology assessment
Efficaey
Safety
Economy
Details
Efficacy and safety of atogepant in prophylactic treatment of migraine: a Meta-analysis
Published on
New Medicine
2024,34(10):1151-1160.
249 times
66 times
SHE Lang
CAI Junlong
TANG Lizhi
SHI Zhihua
CGRP receptor antagonists
Atogepant
Migraine
Meta-analysis
Efficacy
Safety
Details
上一页
1
2
3
4